Metabolites biotransformation

Benzodiazepines undergo extensive and complex metabolism. They are excreted mainly in the urine, largely in the form of several metabolites. Biotransformation processes include mainly hydroxylation and A-dealkylation reactions, whereas the end-products include both free and conjugated compounds (116). Chlordiazepoxide, for example, is metabolized to oxazepam and other metabolites and, depending on its dosage, urine may contain significant concentrations of oxazepam (117). 

For abbreviation of analyte names see Sect. Abbreviations . ACN acetonitrile, a.p. after precipitation, AtrE atropinesterase from rabbit serum, hum human, IS internal standard, metab. metabolites (biotransformation products produced in vivo), MeOH methanol, n.s. not specified, p.p. prior to precipitation Numbers give volume ratio v/v... 

The biotransformation is the sum of the processes by which a pollutant is subject to chemical change in living organisms. During biotransformation a large number of enzymes and pathways are involved and the common activity of most of them is that they transform lypophilic pollutants into more polar metabolites. Biotransformation (metabolic alteration) of pollutant molecules occurs mainly in the liver, but to some extent also in skin, kidney, placenta, plasma, intestine or brain (Nove et al., 2000). Extrahepatic tissues... 

Abstract In the past years, elucidation of transformation products of per- and polyfluorinated chemicals (PFC) has been a task frequently approached by analytical chemists. PCT, such as perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are persistent and thus, the analytical quest to detect transformation products has failed so far. Their prominence as contaminants is mainly due to their extreme persistence, which is linked to their perfluoroalkyl chain length. Molecules that are less heavily fluorinated can show very complex metabolic behavior, as is the case for fluorotelomer alcohols. These compounds are degraded via different but simultaneous pathways, which produce different stable metabolites. Biotransformation processes of PFC may occur when these compounds enter the environment, and thus known and unknown PFC may be generated in these compartments. Therefore, it is essential to determine metabolic pathways of such compounds in order to entirely understand their fate in the environment. This chapter summarizes methodological approaches and instmmental setups which have been implemented in biotransformation studies of PFC and focuses on mass spectrometric methods and the separation techniques coupled to the mass spectrometer (MS). Valuable MS approaches that have not been frequently used in studies on PFC are presented as well. Since compounds carrying C-F bonds exhibit unique properties, these will be initially presented to address the meaning of these properties both for analytical tasks and for the setup of biotransformation experiments. 

The toxic effect depends both on lipid and blood solubility. I his will be illustrated with an example of anesthetic gases. The solubility of dinitrous oxide (N2O) in blood is very small therefore, it very quickly saturates in the blood, and its effect on the central nervous system is quick, but because N,0 is not highly lipid soluble, it does not cause deep anesthesia. Halothane and diethyl ether, in contrast, are very lipid soluble, and their solubility in the blood is also high. Thus, their saturation in the blood takes place slowly. For the same reason, the increase of tissue concentration is a slow process. On the other hand, the depression of the central nervous system may become deep, and may even cause death. During the elimination phase, the same processes occur in reverse order. N2O is rapidly eliminated whereas the elimination of halothane and diethyl ether is slow. In addition, only a small part of halothane and diethyl ether are eliminated via the lungs. They require first biotransformation and then elimination of the metabolites through the kidneys into the... 

The kinetic properties of chemical compounds include their absorption and distribution in the body, theit biotransformation to more soluble forms through metabolic processes in the liver and other metabolic organs, and the excretion of the metabolites in the urine, the bile, the exhaled air, and in the saliva. An important issue in toxicokinetics deals with the formation of reactive toxic intermediates during phase I metabolic reactions (see. Section 5.3.3). 

Biotechnological processes may be divided into fermentation processes and biotransformations. In a fermentation process, products are formed from components in the fermentation broth, as primary or secondary metabolites, by microorganisms or higher cells. Product examples are amino acids, vitamins, or antibiotics such as penicillin or cephalosporin. In these cases, co-solvents are sometimes used for in situ product extraction. 

By carefully examining the fragmentation pattern of the metabolite and comparison with the mass spectra of the precursor molecule, it is often possible to determine not only the nature of the biotransformation, but also its position in the molecule. In the proceeding example, accurate mass measurement was used to determine that a hydroxyl group had been added to the benzene ring containing the fluorine substituent. 

German investigators (Brock et al) worked on the creation of alkylating pro-drugs that have cytostatic activity after specific biotransformation in the tumor tissue. Cyclophosphamide (CTX) has well pronounced antitumor activity with the broadest spectrum. It is metabolized to the cytotoxic phosphoamide mustard. In normal tissues with high enzyme level cyclophosphamide is converted to its inactive metabolites (Fig. 2). These differences in biotransformation can explain the relative selectivity of cyclophosphamide towards... 

Alkylating Agents. Figure 2 Biotransformation of cyclophosphamide - formation of inactive ( ) and toxic ( metabolites. 

Technical-grade endosulfan contains at least 94% a-endosulfan and (3-endosulfan. The a- and (3-isomers are present in the ratio of 7 3, respectively. The majority of the studies discussed below used technical-grade endosulfan. However, a few examined the effects of the pure a- and (3-isomers. Endosulfan sulfate is a reaction product found in technical-grade endosulfan as a result of oxidation, biotransformation, or photolysis. There is very little difference in toxicity between endosulfan and its metabolite, endosulfan sulfate. However, the a-isomer has been shown to be about three times as toxic as the P-isomer of endosulfan. 

In phase 1, the pollutant is converted into a more water-soluble metabolites, by oxidation, hydrolysis, hydration, or reduction. Usually, phase 1 metabolism introduces one or more hydroxyl groups. In phase 2, a water-soluble endogenous species (usually an anion) is attached to the metabolite— very commonly through a hydroxyl group introduced during phase 1. Although this scheme describes the course of most biotransformations of lipophilic xenobiotics, there can be departures from it. 

Residues of PCBs in animal tissues include not only the original congeners themselves, but also hydroxy metabolites that bind to cellular proteins, for example, transthyretin (TTR Klasson-Wehler et al. 1992 Brouwer et al. 1990 Fans et al. 1993). Small residues are also found of methyl-sulfonyl metabolites of certain PCBs (Bakke et al. 1982, 1983). These appear to originate from the formation of glutathione conjugates of primary epoxide metabolites, thus providing further evidence of the existence of epoxide intermediates. Further biotransformation, including methylation, yields methyl-sulfonyl products that are relatively nonpolar and persistent. 

The oxidation of OPs can bring detoxication as well as activation. Oxidative attack can lead to the removal of R groups (oxidative dealkylation), leaving behind P-OH, which ionizes to PO . Such a conversion looks superficially like a hydrolysis, and was sometimes confused with it before the great diversity of P450-catalyzed biotransformations became known. Oxidative deethylation yields polar ionizable metabolites and generally causes detoxication (Eto 1974 Batten and Hutson 1995). Oxidative demethy-lation (0-demethylation) has been demonstrated during the metabolism of malathion. 

---